Related Experiment Video
Updated: Feb 9, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
Prevention and Treatment of Intestinal Failure-Associated Liver Disease in Children
Lorenzo Norsa1, Emanuele Nicastro2, Angelo Di Giorgio3
1Pediatric Gastroenterology Hepatology and Nutrition, Ospedale Papa Giovanni XXIII, 24127 Bergamo, Italy. lnorsa@asst-pg23.it.
Insights
Intestinal failure-associated liver disease (IFALD) in children is a serious complication of long-term parenteral nutrition. Early management and prevention strategies are crucial for managing IFALD and avoiding liver transplantation.
Area of Science:
- Pediatric Gastroenterology
- Hepatology
- Intestinal Rehabilitation
Background:
- Intestinal failure-associated liver disease (IFALD) poses a significant threat to children requiring long-term parenteral nutrition.
- Progressive IFALD can impede intestinal rehabilitation and necessitate combined liver-intestinal transplantation.
- Dedicated intestinal failure centers have successfully reduced IFALD incidence.
Purpose of the Study:
- To review the etiology and risk factors of IFALD.
- To highlight key prevention strategies, including nutritional management and infection control.
- To discuss current and emerging therapeutic interventions for IFALD.
Main Methods:
- Literature review of IFALD etiology, risk factors, prevention, and treatment.
- Analysis of evidence from dedicated intestinal failure centers.
- Synthesis of current medical and surgical treatment strategies.
Main Results:
- Early and proactive management can prevent IFALD progression to end-stage liver disease.
- Nutritional optimization and strict control of catheter-related infections are primary preventive measures.
- Timely intervention can lead to the resolution of IFALD.
Conclusions:
- IFALD is a preventable complication with appropriate management.
- Multidisciplinary care in intestinal failure centers is vital for IFALD prevention and treatment.
- Further research into advanced therapeutic strategies is ongoing.
Abstract:
Intestinal failure-associated liver disease (IFALD) is a threatening complication for children on long-term parenteral nutrition because of intestinal failure. When progressive and intractable, it may jeopardize intestinal rehabilitation and lead to combined liver and intestinal transplantation. The institution of dedicated intestinal failure centers has dramatically decreased the incidence of such complication. IFALD may rapidly fade away if very early management aimed at preventing progression to end-stage liver disease is provided. In this review, we address the etiology and risk factors of IFALD in order to introduce pillars of prevention (nutritional management and catheter-related infections control). The latest evidence of therapeutic strategies, such as medical and surgical treatments, is also discussed.
More Related Videos
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
Coronary Artery Disease IV: Preventive Measures
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...

